Full-Time

Translational Medicine, Precision Medicine

Posted on 11/13/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Entry

Cambridge, MA, USA

Requires on-site presence in Cambridge, MA for at least 50% of the time.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Understanding of oncology, biomarkers, polymerase chain-reaction and next-generation sequencing technology
  • Excellent communication skills, both written and verbal are required
  • Deliver quality work in a timely manner
  • Ability to work following defined process and instructions
  • Highly organized and meticulous
  • Ability to work on-site in Cambridge, MA at least 50% time
  • Knowledge on information storage and inquiry using excel is a strong plus
  • Flexibility with can-do attitude
Responsibilities
  • Works under supervision of Senior Director / Director of Precision Medicine
  • Participates in cross functional team meetings for the development, execution, and implementation of the precision medicine team strategy
  • Conducts data mining of public domain to help characterize performance metrics of diagnostic laboratory tests used by clinical trial sites
  • Compiles new information and evaluate existing information within an existing database to refine and aggregate data about lab tests used by clinical sites
  • Monitors database to ensure timely and accurate entry of required content
  • Proposes opportunities to improve the effectiveness and efficiency of the system and workflow to track lab tests

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's collaboration with Prime Medicine enhances its cell and gene-therapy pipeline.
  • The rise of digital health technologies boosts BMS's R&D efficiency.
  • BMS's focus on biosimilars opens new market opportunities globally.

What critics are saying

  • BMS faces a $6.4 billion lawsuit over Celgene drug approval delays.
  • The 340B Drug Pricing Program lawsuit could lead to regulatory challenges.
  • High financial stakes in the Prime Medicine agreement pose development risks.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE